Daicel Corporation (TYO:4202)

Japan flag Japan · Delayed Price · Currency is JPY
1,399.00
+11.00 (0.79%)
Oct 24, 2025, 3:30 PM JST
0.79%
Market Cap370.91B
Revenue (ttm)580.23B
Net Income (ttm)42.91B
Shares Out265.13M
EPS (ttm)158.91
PE Ratio8.80
Forward PE7.01
Dividend60.00 (4.29%)
Ex-Dividend DateSep 29, 2025
Volume575,600
Average Volume562,665
Open1,390.00
Previous Close1,388.00
Day's Range1,380.50 - 1,399.00
52-Week Range1,057.50 - 1,482.00
Beta0.20
RSI60.39
Earnings DateNov 6, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photo... [Read more]

Sector Materials
Founded 1919
Employees 11,178
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4202
Full Company Profile

Financial Performance

In 2024, Daicel's revenue was 586.53 billion, an increase of 5.10% compared to the previous year's 558.06 billion. Earnings were 49.48 billion, a decrease of -11.38%.

Financial Statements

News

There is no news available yet.